Based on data from the past 90 days ending February 07, 2026, Heron Therapeutics's three largest insider shareholders are TenPercentOwner Capital Management Lp Rubric (30.05Mn shares), Director Adam Morgan (8.88Mn shares), Chief Executive Officer Craig A Collard (571.71K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Management Lp Rubric | 30,046,828 | 17 Oct, 2025 | |
| Adam Morgan | 8,877,027 | 03 Feb, 2026 | |
| Craig A Collard | Chief Executive Officer | 571,710 | 03 Feb, 2026 |
| Ira Duarte | Evp And Chief Financial Officer | 195,356 | 03 Feb, 2026 |
| William P Forbes | Evp And Chief Development Officer | 181,773 | 03 Feb, 2026 |
| Barry D Quart | Chief Executive Officer | 177,989 | 17 Jan, 2023 |
| Susan Rodriguez | 87,180 | 04 Feb, 2025 | |
| Lisa Peraza | Vp And Chief Accounting Officer | 55,907 | 16 Jan, 2024 |
| Thomas Cusack | 53,960 | 03 Feb, 2026 | |
| Craig A Johnson | 53,960 | 03 Feb, 2026 | |
| Waage Christian | 53,960 | 03 Feb, 2026 | |
| Michael Kaseta | 53,960 | 03 Feb, 2026 | |
| Sharmila Dissanaike | 53,960 | 03 Feb, 2026 | |
| Stephen Davis | 52,032 | 20 Dec, 2022 | |
| John Poyhonen | President & Cco | 46,648 | 17 Apr, 2023 |
| David Leslie Szekeres | Evp And Chief Operating Officer | 33,754 | 17 Jul, 2023 |
| Kimberly Manhard | Evp And Drug Development | 28,330 | 17 Apr, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Jan, 2026 | William P Forbes | Common Stock | A | 11,695 | - | 181,773 | D | M |
| 31 Jan, 2026 | Craig A Collard | Common Stock | A | 34,789 | - | 571,710 | D | M |
| 31 Jan, 2026 | Ira Duarte | Common Stock | A | 11,695 | - | 195,356 | D | M |
| 30 Jan, 2026 | Craig A Johnson | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Waage Christian | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Michael Kaseta | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Sharmila Dissanaike | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Thomas Cusack | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 19 Jan, 2026 | William P Forbes | Common Stock | A | 3,875 | - | 170,078 | D | M |
| 19 Jan, 2026 | Craig A Collard | Common Stock | A | 13,797 | - | 536,921 | D | M |
| 19 Jan, 2026 | Ira Duarte | Common Stock | A | 3,875 | - | 183,661 | D | M |
| 08 Nov, 2025 | Thomas Cusack | Common Stock | A | 37,879 | - | 37,879 | D | A |
| 31 Oct, 2025 | William P Forbes | Common Stock | A | 11,694 | - | 166,203 | D | M |
| 31 Oct, 2025 | Craig A Collard | Common Stock | A | 34,789 | - | 523,124 | D | M |
| 31 Oct, 2025 | Ira Duarte | Common Stock | A | 11,694 | - | 179,786 | D | M |
| 19 Oct, 2025 | William P Forbes | Common Stock | A | 3,874 | - | 154,509 | D | M |
| 19 Oct, 2025 | Craig A Collard | Common Stock | A | 13,797 | - | 488,335 | D | M |
| 19 Oct, 2025 | Ira Duarte | Common Stock | A | 3,874 | - | 168,092 | D | M |
| 15 Oct, 2025 | Capital Management Lp Rubric | Common Stock, par value $0.01 per share ("Common Stock") | A | 946,100 | - | 30,046,828 | I | C |